VIDARIS AUTOLOGOUS SERUM EYE DROPS Trademark

Trademark Overview

On Monday, April 16, 2018, a trademark application was filed for VIDARIS AUTOLOGOUS SERUM EYE DROPS with the United States Patent and Trademark Office. The USPTO has given the VIDARIS AUTOLOGOUS SERUM EYE DROPS trademark a serial number of 87877813. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, May 2, 2025. This trademark is owned by DCI Donor Services, Inc.. The VIDARIS AUTOLOGOUS SERUM EYE DROPS trademark is filed in the Pharmaceutical Products category with the following description:

Eye drops; artificial tears; autologous serum eye drops; blood serum for treatment of eyes for medical purposes
vidaris autologous serum eye drops

General Information

Serial Number87877813
Word MarkVIDARIS AUTOLOGOUS SERUM EYE DROPS
Filing DateMonday, April 16, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, May 2, 2025
Registration Number5956380
Registration DateTuesday, January 7, 2020
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 25, 2018

Trademark Statements

Description of MarkThe mark consists of an ovular design comprised of curved lines above the words "VIDARIS AUTOLOGOUS SERUM EYE DROPS".
Goods and ServicesEye drops; artificial tears; autologous serum eye drops; blood serum for treatment of eyes for medical purposes
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"AUTOLOGOUS SERUM EYE DROPS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 23, 2018
Primary Code005
First Use Anywhere DateMonday, April 16, 2018
First Use In Commerce DateMonday, April 16, 2018

Trademark Owner History

Party NameDCI Donor Services, Inc.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressNashville, TN 37228
Party NameDCI Donor Services, Inc.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNashville, TN 372033034
Party NameDCI Donor Services, Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNashville, TN 372033034

Trademark Events

Event DateEvent Description
Tuesday, April 24, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, April 19, 2018NEW APPLICATION ENTERED
Monday, April 23, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, August 5, 2018ASSIGNED TO EXAMINER
Monday, August 13, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, August 13, 2018EXAMINERS AMENDMENT E-MAILED
Monday, August 13, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 13, 2018EXAMINER'S AMENDMENT ENTERED
Monday, August 13, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 23, 2018ASSIGNED TO LIE
Wednesday, September 5, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 25, 2018PUBLISHED FOR OPPOSITION
Tuesday, September 25, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 20, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 20, 2019SOU TEAS EXTENSION RECEIVED
Monday, May 20, 2019SOU EXTENSION 1 FILED
Monday, May 20, 2019SOU EXTENSION 1 GRANTED
Wednesday, May 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 30, 2019ASSIGNED TO EXAMINER
Wednesday, November 20, 2019USE AMENDMENT FILED
Wednesday, November 20, 2019TEAS STATEMENT OF USE RECEIVED
Saturday, November 30, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, December 2, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, November 30, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 7, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 3, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 7, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, January 15, 2025TEAS SECTION 8 & 15 RECEIVED
Friday, May 2, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, May 2, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, May 2, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

drops serum autologous vidaris eyes medical purposes treatment blood artificial tears